News

GSK’s new asthma drug Relvar Ellipta has shown itself to be superior to existing treatments in a major real world trial, the Salford Lung Study (SLS). Developed with US respiratory specialist ...
The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough designation.
Umeclidinium bromide/vilanterol trifenatate inhalation powder is indicated for the long-term, once-daily maintenance ...
Menstrual migraine affects more than half of people with both periods and migraine. Find out what you can do to manage this ...
Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective ...
Researchers have shown a new drug compound can prevent long COVID symptoms in mice – a landmark finding that could lead to a future treatment for the debilitating condition.
Purpose: The pharmacology, pharmaceutics, clinical efficacy, adverse effects, cost, and dosage and administration of long-acting risperidone injection are reviewed. Summary: Risperidone is the ...
Milestone Pharmaceuticals' stock fell 50% after the FDA's CRL for CMC issues, but the drug Etripamil has shown efficacy and ...
University of Florida scientists have helped identify a novel drug compound that selectively activates pain-altering ...
Here, we explored how NMDARs signal in tLTD. We found that, regardless of frequency, L5 PC→PC tLTD relies on the non-ionotropic preNMDAR signaling pathway mediated by JNK2, which helps to resolve the ...
For individuals with dominantly inherited Alzheimer disease (DIAD), long-term treatment with gantenerumab may delay clinical decline.
At the recent ATTD 2025 meeting, participants discussed recent progress and remaining challenges in developing a fully closed ...